Medication for therapy or prophylaxis of asthma

Abstract

A medication for therapy or prophylaxis of asthma, comprises a ginger compound selected from a group of [6]-gingerol, [10]-gingerol, [6]-shogaol and [6]-gingerol; and an acceptable carrier or excipient, which can relieve the airway remodeling symptoms of asthma, particularly to phthalate induced airway remodeling, by suppressing the proliferation and migration of bronchial smooth muscle cells and reducing the instances of fatal asthma.

1 . A medication for therapy or prophylaxis of asthma, comprising:
 a ginger compound selected from a group of [6]-gingerol, [10]-gingerol, [6]-shogaol and [6]-gingerol; and   an acceptable carrier or excipient.   
     
     
         2 . The medication for therapy or prophylaxis of asthma as defined in  claim 1 , wherein the medication is for suppressing air remodeling symptom of asthma. 
     
     
         3 . The medication for therapy or prophylaxis of asthma as defined in  claim 1 , wherein the medication is for suppressing the proliferation and migration of bronchial smooth muscle cells. 
     
     
         4 . The medication for therapy or prophylaxis of asthma as defined in  claim 3 , wherein the medication is for suppressing air remodeling symptom of asthma caused by phthalate esters. 
     
     
         5 . The medication for therapy or prophylaxis of asthma as defined in  claim 4 , wherein the phthalate esters includes buthylbenzyl phthalate, bis-(2-ethylhexyl) phthalate, dibutyl phthalate, and diethyl phthalate. 
     
     
         6 . The medication for therapy or prophylaxis of asthma as defined in  claim 1 , wherein the medication is in the form of powders, a pill, a tablet, drops or solution.